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Abstract
Heterotopic ossification (HO) is a debilitating condition defined by the rapid formation of bone in soft tissues. What makes HO
fascinating is first the rate at which bone is deposited, and second the fact that this bone is structurally and compositionally
similar to that of a healthy adult. If the mechanisms governing HO are understood, they have the potential to be exploited for
the development of potent osteoinductive therapies. With this aim, a tissue-engineered skeletal muscle was used model to better
understand the role of inflammation on this debilitating phenomenon. It was shown that myoblasts could be divided into two
distinct populations: myogenic cells and undifferentiated ‘reserve’ cells. Gene expression analysis of myogenic and
osteoregulatory markers confirmed that ‘reserve’ cells were primed for osteogenic differentiation but had a reduced capacity
for myogenesis. Osteogenic differentiation was significantly enhanced in the presence of platelet-derived growth factor
(PDGF)-BB and bone morphogenetic protein 2 (BMP2), and correlated with conversion to a Sca-1+/CD73+ phenotype. Alizarin
red staining showed that PDGF-BB promoted significantly more mineral deposition than BMP2. Finally, it was shown that
PDGF-induced mineralization was blocked in the presence of the pro-inflammatory cytokines tumour necrosis factor-α and
interleukin 1. In conclusion, the present study identified that PDGF-BB is a potent osteoinductive factor in a model of
tissue-engineered skeletal muscle, and that the osteogenic capacity of this protein was modulated in the presence of
pro-inflammatory cytokines. These findings reveal a possible mechanism by which HO develops following trauma. Importantly,
these findings have implications for the induction and control of bone formation for regenerative medicine. Copyright © 2016
John Wiley & Sons, Ltd.
Received 5 May 2016; Revised 27 July 2016; Accepted 26 September 2016
Keywords bone; PDGF; skeletal muscle; inflammation; osteoprogenitor; heterotopic ossification
1. Introduction
Heterotopic ossification (HO) is a debilitating condition
defined by the de novo formation of bone within non-
osseous soft tissues. The formation of bone at atypical
sites can have serious consequences such as neurovascular
entrapment, and has a significant impact on an individ-
ual’s quality of life (Colachis et al., 2004). Acquired HO
is associated with severe trauma that can result as a
consequence of injuries, burns or changes in local biome-
chanics following reparative surgeries (Davies et al.,
2015). Despite continued efforts to determine the cellular
and molecular events governing HO, the underlying
mechanisms remain elusive. One of the body’s initial
responses to trauma is to mount a hyper-inflammatory
response, via the recruitment of cells through the local
vasculature (Lenz et al., 2007). Previous studies have
identified an association between inflammatory cytokine
and chemokine expression and heterotopic ossification
(Evans et al., 2012), and it has been suggested that certain
combinations of these proteins may be used to predict the
onset of HO (Forsberg et al., 2014). However, at present,
the exact relationship between post-trauma inflammation
and HO remains unknown.
To date, several studies have attempted to profile cyto-
kines present within the local wound microenvironment
and circulation following traumatic insult. These studies
have identified systemic and local upregulation of inflam-
matory cytokines such as interleukins (IL) and tumour
necrosis factor alpha (TNFα) (Evans et al., 2012; Forsberg
et al., 2014), as well as growth factors such as
transforming growth factor beta (TGFβ), insulin-like
growth factor (IGF) and platelet-derived growth factor
(PDGF) (Pasinetti et al., 1993; Kim et al., 1996). Evidence
identifying a possible link between the presence of a
hyper-inflammatory environment and the development
of ectopic ossification was provided when mesenchymal
stem cell cultures were shown to undergo osteogenic dif-
ferentiation following exposure to the wound effluent of
blast-injured mice (Cadosch et al., 2010). Evidence of an
association between post-trauma inflammation and
ectopic bone formation has also been acquired in skeletal
muscle cultures, where exposure to serum derived from
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traumatic brain injury (TBI) patients was shown to lead to
increased local proliferation and subsequent tissue miner-
alization (Cadosch et al., 2010).
Skeletal muscle represents one of the primary sites of
HO. It contains several populations of cells with a capacity
for osteogenic differentiation. However, the contribution
of these endogenous cells to HO remains largely
unknown. Possible contributors include satellite cells
and a number of mesenchymal progenitor cells such as
interstitial cells (PDGFRα+/Sca-1+), muscle-derived
haematopoietic stem cells (CD45+/Sca-1+) and CD31–/
CD45– side population mesenchymal stem cells (Peault
et al., 2007). However, osteogenic differentiation within
skeletal muscle is not restricted to multipotent progenitors
and resident stem cells. A capacity for osteogenic
differentiation has also been observed within the resident
myogenic cell population (Liu et al., 2009), with rat (L6
cells) and mouse (C2C12 cells) skeletal muscle cells
shown to undergo osteogenic differentiation after
treatment with osteogenic inducers, such as BMP2 or
IL17 (Katagiri et al., 1994; Kocic et al., 2012). Myoblast
ossification has also been shown to occur via myoblast
dedifferentiation to an uncommitted and multipotent pro-
genitor. Such reversion has been observed in the presence
of TGFβ (Mu and Li, 2011), where incubation of primary
myoblasts with a transient and small concentration of this
cytokine has promoted the expression of primitive skeletal
muscle markers, Pax7 and Sca-1. To date, several TGFβ
isoforms have been identified in both immature and
mature ectopic ossifications, with this cytokine likely to
play a temporal role in HO (Suutre et al., 2009). This
has led us to hypothesize that the presence of biochemical
factors within the wound environment during skeletal
muscle repair and regeneration could lead to the
misdirected differentiation of endogenous skeletal muscle
progenitors to an osteogenic phenotype (Figure 1).
The mechanism by which ectopic ossification occurs is a
largely unknown phenomenon, primarily owing to the over-
whelming complexity of the body’s post-trauma response.
In order to gain a better understanding of the complex pro-
cesses governing HO a tissue engineered skeletal muscle
model has been utilised, in a manner analogous to muscle
damage and regeneration, to analyse the influence of in-
flammatory cytokines on heterotopic ossification. Inflamma-
tory factors were selected based on proteomic studies of
serum and wound effluent following trauma (Pasinetti
et al., 1993; Kim et al., 1996; Evans et al., 2012). It is be-
lieved that this currently represents the only tissue-
engineered model of HO, and it is anticipated that it will
complement current animal models to better understand
this complex and debilitating condition.
2. Materials and methods
2.1. Cell culture
In the present study, C2C12 immortalized murine myoblasts
(CRL-1772; ATCC, Rockville, MD, USA) were used between
passages six and nine. Cells were grown in T175 flasks in a
humidified 5% CO2 atmosphere at 37°C in growth medium
composed of high glucose Dulbecco’s Modified Eagle Me-
dium (DMEM) (Sigma-Aldrich, Cambridge, UK) containing
20% fetal bovine serum (FBS) (PAA Laboratories Ltd.,
Yeovil, UK) and 1% penicillin/streptomycin (Thermo Fisher
Scientific, Paisley, UK).
2.2. Preparation of tissue-engineered skeletal muscle
To produce tethered collagen constructs, 1.3 ml type I
rat-tail collagen (in 0.1 M acetic acid, protein
Figure 1. Hypothetical representation of how osteogenic progenitors may be derived from satellite cells activated following skeletal muscle trauma. SC, satellite cell; MDPC, mus-
cle-derived precursor cell; OPC, osteogenic progenitor cell. Arrow size represents the relative proportion of cells likely to differentiate down a given lineage.
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concentration of 2.035 mg/ml) (First Link Ltd., Wolver-
hampton, UK) was added to 0.15 ml 10×Minimum Essen-
tial Medium (MEM) (Gibco) and mixed thoroughly. The
acidic solution was neutralized in a drop-wise manner
using 5 M and 1 M sodium hydroxide (VWR, Lutterworth,
UK) until a colour change (yellow to pink) was observed.
The neutralized collagen solution was mixed with a sus-
pension of 0.15 ml growth medium containing 6 × 106
C2C12 cells. A 1.5 ml aliquot of complete collagen/cell so-
lution was pipetted into a rectangular well culture plate
(Cat#267062, 37.6 × 27.9 mm; Nunc, Rochester, USA),
which had been converted to 2.5 × 7.3 × 1.5 cm dimen-
sions using an impermeable strip of silicone elastomer
mould (Univar, Bradford, UK). Longitudinal lines of uniax-
ial tension were created through the collagen gel by tether-
ing it at each end with bespoke polyethylene mesh flotation
bars (Darice Inc., Strongsville, OH, USA) that had been
bound together using stainless steel orthodontic wire.
Culture plates were placed in a humidified incubator at
37°C for 30 min to allow gelation of the collagen matrix.
Once set, the construct was detached from the sides and
base of the culture dish using a sterile needle, and the sil-
icone moulds removed. The constructs were cultured in
5 ml growth medium for a period of 4 days, with the me-
dium changed twice daily. To induce myoblast fusion, at
day 5 growth medium was replaced with myogenic me-
dium, which was composed of high-glucose DMEM con-
taining 2% horse serum (Sigma) and 1%
penicillin/streptomycin. Constructs were cultured in myo-
genic medium for a period of 10 days, with daily medium
changes.
2.3. Fluorescence and confocal microscopy
Tissue-engineered skeletal muscle constructs were
washed with 1% Tris-buffered saline (TBS) to remove cul-
ture medium and fixed using methanol–acetone (1:1)
(Sigma) for 30 min at room temperature. Fixative was re-
moved and constructs washed twice with 1% TBS. A
blocking solution composed of 5% goat serum (Gibco)
and 0.2% triton-X (Sigma) was made up in 1% TBS. Each
construct was immersed in 500 μl blocking solution for
2 h at room temperature. Blocking solution was replaced
with 500 μl primary antibody solution [1:200 rabbit
anti-desmin (ab86083; Abcam, Cambridge, UK), 2% goat
serum, 0.2% triton-X, made up in TBS] and each construct
was incubated at room temperature overnight. Primary
antibody solution was removed and each construct
washed extensively with 1% TBS. A secondary antibody
solution was prepared containing 1:200 goat anti-rabbit
tetramethylrhodamine (TRITC, ab6718; Abcam), 2% goat
serum, 0.2% triton-x made up in 1% TBS. Constructs were
incubated in the dark at room temperature with second-
ary antibody solution for 2 h. The solution was removed
and the constructs washed extensively with 1% TBS. To
visualise nuclei each construct was incubated with
40,6-diamidino-2-phenylindole (DAPI; Sigma), 1:10 000
dilution in 1% TBS, for 10 min at room temperature.
Constructs were washed using 1% TBS and mounted
using DPX mounting medium (Sigma). Aligned myotubes
were visualized using both a Leica DM2500 fluorescence
microscope (Leica, Cambridge, UK) and a Zeiss LSM780
confocal microscope (Zeiss, Oberkochen, Germany). Con-
focal image reconstruction and scale measurements were
performed using Zen software (Zeiss). Scale measure-
ments for images obtained using the fluorescence micro-
scope were generated using ImageJ software.
2.4. Factorial design of experiment
The independent and combinatorial effects of growth fac-
tors and cytokines identified in serum/effluent were in-
vestigated following trauma on tissue engineered
skeletal muscle. A total of 16 combinations of
growth/inflammatory factors were examined. Eight fac-
tors were examined in a two-level (present or not) full fac-
torial design: IL1β (0.02 ng/ml; Barksby et al., 2006), IL6
(10 ng/ml; Nasi et al., 2015), PDGF-BB (2 ng/ml; Zhao
et al., 2016), TNFα (1 ng/ml; Lam et al., 2000), TGFβ
(1 ng/ml; Pfeilschifter et al., 1990), BMP2 (300 ng/ml;
Katagiri et al., 1994), basic fibroblast growth factor
(bFGF) (1 ng/ml; Coipeau et al., 2009) and IGF-1
(2 ng/ml; Blumenfeld et al., 2000). Concentrations used
were consistent with those documented throughout the
literature. After 14 days’ culture, mature tissue-
engineered skeletal muscle was exposed to each treat-
ment. All proteins were dissolved in 7 ml myogenic me-
dium and added to tissue-engineered skeletal muscle
cultures for 3 days. All experiments were designed and
analysed using MiniTAB statistical software version 16
(MiniTAB Inc., State College, PA, USA). All recombinant
proteins were purchased from Peprotech (Rocky Hill, NJ,
USA).
2.5. Isolation of undifferentiated C2C12 myoblasts from
tethered collagen gels
To isolate cells from the three-dimensional (3D) collagen
matrix for flow cytometry profiling and quantitative real-
time reverse transcription polymerase chain reaction
(qRT-RT-PCR) analysis, the gels were placed in 50 ml
centrifuge tubes (Fisher Scientific, Loughborough, UK)
containing 0.1% type I collagenase (Sigma) made up in
4 ml unsupplemented DMEM (Figure 2). Based on data
generated from preliminary studies, the gels were
digested for a period of 40 min at 37°C and 5% CO2.
When the gels had been fully digested the solution was
neutralized through the addition of an equal volume of
growth medium (20% FBS). The total cell population
was collected by pelleting at 2000 g for 5 min. The hetero-
geneous mixture of myogenic and undifferentiated cells
was seeded in 6-well plates (Nunc). Myotubes did not ad-
here to tissue culture polystyrene when plated. Fragments
of non-adherent myotubes were removed after 24 h of cul-
ture and the medium renewed. Undifferentiated C2C12s
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were selected using this method. All images were cap-
tured using a Leica DMIL LED microscope (Leica).
2.6. Osteogenic differentiation of untreated ‘reserve’ cells
High-glucose DMEM was supplemented with 50 μg/ml
ascorbic acid (Sigma) and 10 mM β-glycerophosphate
(Sigma). Osteogenic medium was applied to undifferenti-
ated cells isolated from tissue-engineered skeletal muscle
and C2C12 controls. All cells were seeded at a density of
1.5 × 104 cells/cm2 and cultured in osteogenic medium
for a period of 14 days. Medium was changed every 3 days.
2.7. Osteogenic differentiation of ‘reserve’ cells exposed to
growth/inflammatory factors
‘Reserve’ C2C12s that had been exposed to recombinant
growth factors and cytokines in 3D were isolated as previ-
ously described and seeded at a density of 1.5 × 104
cells/cm2 and cultured in the presence of myogenic me-
dium at 37°C and 5% CO2. Note that these cells were
not exposed to osteogenic differentiation medium. ‘Re-
serve’ C2C12s that had not been exposed to
inflammatory/growth factors and C2C12s previously cul-
tured in two dimensions were used as controls. All cells
were cultured at 37°C and 5% CO2 for 48 h.
2.8. Alizarin red staining and quantification
Each culture was fixed using methanol–acetone (1:1) for
20 min at room temperature. Fixed cultures were stained
at room temperature for a period of 20 min using 40 mM
Alizarin red (AR; Sigma). To ensure even distribution of
AR stain cultures were placed on a Max400 orbital shaker
(Thermo Scientific), which provided gentle agitation. Un-
bound stain was eluted by successive washes in phosphate-
buffered saline (PBS). Images of AR stained cultures were
captured using a DMIL LED microscope (Leica). Bound AR
stain was eluted using 10% (v/v) acetic acid (Fisher Scien-
tific) and quantified using a Varioskan Flash plate reader
(Thermo Scientific) at a wavelength of 405 nm.
2.9. Flow cytometry
All analysis and cell sorting was performed using a BD
FACSJazz™ instrument (Becton Dickinson
Immunocytometry Systems, Oxford, UK) and analysed
using FlowJo version 10 software (De Novo Software,
Los Angeles, CA, USA). In preparation for fluorescence-
activated cell sorting (FACS) analysis unfused cells were
counted (1:1 Trypan blue) using a haemocytometer and
resuspended in ice-cold sterile PBS containing 1% FBS at
a density of 1 × 106 cells/ml. Conjugated primary anti-
bodies raised against Sca-1 (APC conjugated, 17-5981;
eBioscience Ltd., San Diego, CA, USA) and CD73 (PE-
Cy7 conjugated, 25-0731; eBioscience Ltd., San Diego,
CA, USA) were added in combination and cultures incu-
bated in the dark at room temperature for 30 min. To re-
move unbound stain, cells were resuspended in sterile
PBS and centrifuged at 400 g for 5 min. This washing step
was repeated three times. For cell selection the
FACSJazz™ instrument was equipped with an 85 μm noz-
zle, and cells were processed at a low sort rate using a
pressure of 45 psi (310KPa). Cells were acquired and
gated using forward scatter (FSC) and side scatter (SSC)
parameters to exclude cell debris and aggregates.
Propidium iodide (PI) staining (00-6990-50e; Biosci-
ences) was used to identify and exclude non-viable cells.
These cells were excluded before analysis.
2.10. Quantitative real-time PCR
Briefly, total RNA was extracted by resuspending cells in
500 μl TRI reagent (Invitrogen, Paisley, UK), according
to the manufacturer’s instructions. RNA was
Figure 2. Schematic representation of the method used for isolating undifferentiated ‘reserve’ cells from tissue-engineered skeletal muscle constructs.
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phase-separated in chloroform and precipitated using
isopropanol (both Sigma). Total RNA concentration was
determined for each sample using a NanoDrop 2000 spec-
trophotometer (Thermo Scientific). All primers were
predesigned and purchased from Sigma-Aldrich (Table 1
) (Kicqstart primers; Sigma, Irvine, UK). Quantitative
real-time RT-PCR was performed using Quantifast™
SYBR® Green RT-PCR one-step kit on a ViiA™ 7 Real-Time
PCR system (Life Technologies). Parameters used were:
hold 50°C for 10°min, 95°C for 5 min, 95°C for 10 s,
60°C for 30 s. Upon completion, dissociation/melting
curve analyses were performed to exclude non-specific
amplifications and primer dimers. The PCR data were nor-
malized to the reference gene ribosomal protein IIB
(RPIIB). Relative gene expression levels were calculated
from the cycle threshold (Ct) value using the comparative
Ct equation (ΔΔCt) or Livak method, where relative gene
expression is calculated as 2–ΔΔCt.
2.11. Data analysis and statistics
ANOVA was performed using SPSS 10.0 for Windows
(SPSS Inc., Chicago, IL, USA). Principal component analy-
sis was performed using MiniTAB® v. 16 (Minitab Inc.,
State College, PA, USA) statistical software to analyse
main and interactive effects. This programme applied lin-
ear regression to analyse main effects and two-way inter-
actions. P-values less than 0.05 were considered
statistically significant.
3. Results
The C2C12 myoblasts cultured in tissue engineered colla-
gen gels could be separated into distinct myogenic and
non-myogenic ‘reserve’ cell populations. Myogenic cells
aligned and fused to form myotubes when cultured in a
3D environment in the presence of myogenic medium
(Figure 3a). ‘Reserve’ cells did not form myotubes when
cultured in three dimensions (Figure 3b) and displayed
limited myogenic differentiation when isolated and cul-
ture in two dimensions, even in the presence of myogenic
medium (Figure 3c). Both myogenic and ‘reserve’ cell
populations stained positively for the intermediate
filament protein desmin (Figure 3bII,cII), which is
routinely used to identify cells of a myoblast lineage.
Quantitative real-time PCR analysis was used to compare
the myogenic gene expression profile of ‘reserve’ cells
with C2C12 controls that had not undergone 3D selection.
‘Reserve’ cells displayed no significant change in MyoD1
expression. However, these cells exhibited a significantly
reduced expression of the satellite cell marker Pax7, and
the myoblast fusion marker, Myogenin (Figure 3d).
It was next determined whether undifferentiated
‘reserve’ cells isolated from tissue-engineered muscle were
capable of producing a calcified matrix when cultured in
the presence of osteogenic medium for a period of 14 days.
Alizarin red staining was used to identify the presence of
calcified nodules and the results compared with a C2C12
population that had not undergone 3D selection. The AR
staining and quantification showed no significant differ-
ences in mineralization between ‘reserve’ and control
C2C12 cultures (Figure 4a,b). Gene expression analysis
showed that ‘reserve’ cells exhibited a significantly
increased expression in the master osteogenic regulator,
Runx2 (Figure 4c) and it is believed that this was
indicative of cells primed for osteogenic differentiation.
However, the addition of exogenous factors is likely
required to induce mineralization. No comparative
increase was observed for the expression of SP7 between
‘reserve’ cells and C2C12 controls (Figure 4c).
The presence of a hyper-inflammatory environment
following trauma is well established. Hence, whether
factors upregulated at the wound site following trauma
could promote mineralization within the isolated ‘reserve’
cell population was evaluated next. The results demon-
strated that exposure of 3D muscle constructs to BMP2
led to mineral deposition within the ‘reserve’ population
following their isolation and expansion in two dimensions
(Figure 5a,b). Flow cytometry profiling identified that
mineralization within the ‘reserve’ population correlated
with a significant increase in the proportion of cells
displaying a Sca-1+/CD73+ phenotype (Figure 5a,b).
The proportion of Sca-1+/CD73+ cells in cultures exposed
to TNFα (1%), IL1 (1%), IL6 (0%), IGF-1 (0%) and bFGF
(8%) was negligible, and no subsequent mineralization
was observed (Figure 5a–c). Exposure to TGF-β caused a
19% increase in Sca-1+/CD73+ phenotype and small
sporadic areas of mineral deposition. No significant
changes were observed in the expression of mesenchymal
stem cell (MSC) surface markers CD90, CD105 or CD140
for any of the treatments analysed (data not included).
Exposure to PDGF-BB promoted significantly more
mineralization when compared with BMP2 treatment
(Figure 5c). A qRT-RT-PCR analysis of osteogenic
regulator genes identified a significantly higher
expression of Runx2 and SP7 in PDGF-BB cultures
compared with BMP2 cultures (Figure 5d).
As the body’s hyperinflammatory response to trauma is
characterized by the presence of a large number of pro-
teins associated with repair and chemotaxis, how
Table 1. A list of primers used for quantitative real-time reverse-transcription poly-
merase chain reaction gene expression analysis
Gene Sequence (50–30) Accession Number
RPIIB F-GGTCAGAAGGGAACTTGTGGTAT NM_153798.2
R-GCATCATTAAATGGAGTAGGCGTC
MyoD1 F-CGCTCCAACTGCTCTGATGGCA NM_010866.2
R-TGCTGCTGCAGTCGATCTCTCA
Myog F-GCAATGCACTGGAGTTCG NM_031189.2
R-ACGATGGACGTAAGGGAGTG
Pax7 F-GACAAGAAAGAAGAAGATGGC NM_011039.2
R-GTTCTGATTCCACATCTGAG
Runx2 F-ACAAGGACAGAGTCAGATTAC NM_1145920.2
R-CAGTGTCATCATCTGAAATACG
Sp7 F-TGCTTGAGGAAGAAGCTC NM_130458.3
R-CTTCTTTGTGCCTCCTTTC
Ptch1 F-CAACCAAACCTCTTGATGTG NM_008957.2
R-CTCAAAGAGACCTAAGAGGTAG
All KiCqStart® SYBR Green primers were purchased from Sigma-Aldrich, Irvine, UK.
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combinations of these factors affected mineralization in
the ‘reserve’ cell population was examined. To this end
principal component analysis (PCA) was applied to exam-
ine the main effects of selected growth/inflammatory
factors on conversion to a Sca-1+/CD73+ phenotype
(Figure 5). Results showed that a Sca-1+/CD73+ pheno-
type was observed for all treatments (Figure 6a,b) exclud-
ing the untreated control (Figure 6b,d). Linear regression
analysis of the main effects of each factor identified that
BMP2 (p < 0.05), PDGF-BB (p < 0.05), IL6 (p < 0.05)
and bFGF (p < 0.05) significantly contributed to the
generation of a Sca-1+/CD73+ phenotype when added
in the 16 combinations analysed (Figure 6c). Both TGF-β
and IGF-1 caused the most significant (p < 0.005)
increases in Sca-1+/CD73+ phenotype, highlighting the
possibility of indirect effects of these growth factors on
mineralization within the ‘reserve cell’ population. In
contrast, inclusion of TNFα or IL1 led to a significant
reduction in the proportion of cells presenting with a
Sca-1+/CD73+ phenotype (Figure 6c).
Identification of a potential link between mineralization
and an increase in Sca-1+/CD73+ phenotype, together
with the conclusions derived from PCA (Figure 6) led to
examination of the potential modulatory effects of TNFα
and IL1 in the presence of PDGF-induced mineralization.
Using flow cytometry profiling it was identified that the
proportion of Sca-1+/CD73+ cells formed following expo-
sure to PDGF-BB (41%) was significantly reduced in the
presence of IL1 (19.7%, p < 0.05), TNFα/IL1 (20.5%,
p < 0.05) and TNFα (8.64%, p < 0.005) (Figure 7a). Sub-
sequent AR staining and quantification showed that
mineralization induced by exposure to PDGF-BB was
prevented in the presence of all three conditions: TNFα,
IL1 and TNFα/IL1 (Figure 7b,c).
As exposure to TNFα caused the most significant reduc-
tion in Sca-1+/CD73+ phenotype, attention was focused
on further characterizing the potential osteoinhibitory
effects of this cytokine on PDGF-BB osteoinduced
cultures. A qRT-RT-PCR analysis identified a significant
reduction in the expression of osteogenic regulators
Figure 3. Tissue-engineered skeletal muscle constructs contained populations of myogenic and undifferentiated ‘reserve’ C2C12s. (a) A three-dimensional tissue-engineered col-
lagen gel (i) promoting the fusion and alignment of C2C12 myoblasts, as shown by fluorescence (ii) and confocal (iii) images. (b) Photomicrographs (i) of cells released from
collagenase type-I digested collagen gels, identifying a population of undifferentiated ‘reserve’ cells that did not contribute to the formation of myotubes but exhibited desmin
positivity (ii). (c) Three-day culture of these ‘reserve’ cells in a two-dimensional environment in the presence of myogenic medium promoted only limited myogenic differentia-
tion when compared with C2C12 controls. (d) quantitative real-time reverse-transcription polymerase chain reaction analysis of relative fold-change in mRNA expression for ‘re-
serve’ cells showed significant reductions in the expression of Pax7 (p < 0.05) and myogenin (p < 0.005) when compared with C2C12s cultured in two dimensions. Bar: 100 μm.
*p < 0.05, **p < 0.005. PCR data represented as mean ± standard deviation (n = 3).
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Runx2 and Sp7 in PDGF-BB cultures exposed to TNFα
(Figure 7d). The presence of TNFα in PDGF-BB cultures
also resulted in a significantly lower expression of the
hedgehog signalling protein Patched 1 (Ptch1) (Figure 7
d). Finally, PCR data showed that the addition of TNFα
to PDGF-BB cultures caused the expression of Runx2 to
fall significantly below that of the untreated controls
(Figure 7d).
4. Discussion
The C2C12 myoblasts in 3D culture contained both myo-
genic and undifferentiated ‘reserve’ cell populations.
‘Reserve’ C2C12s that had not differentiated to form
myotubes exhibited limited myogenic potential after isola-
tion from 3D gels and subsequent culture in myogenic
medium. These findings contribute to data identifying
heterogeneity within the C2C12 population (Deato and
Tjian, 2007) and identify distinct similarities between
‘reserve’ cells and satellite cells (Chakkalakal et al.,
2014). Further similarity is found when one considers that
both C2C12s and satellite cells can be osteogenically
induced in the presence of BMPs (Katagiri et al., 1994;
Asakura et al., 2001). In particular, examination of genes
expressed temporally during myogenesis identified
similarities between ‘reserve’ cells and activated satellite
cells, which are no longer quiescent but primed for differ-
entiation. Much like activated satellite cells, ‘reserve’ cells
downregulated their expression of the quiescence marker
Pax7 in relation to the myogenic regulatory factor, MyoD1
(Stuelsatz et al., 2010). Expression of MyoD1 is often
found to be reduced in cells committed to an osteogenic
lineage (Ono et al., 2011). However, a study by Komaki
et al. (2004) has shown that MyoD1 expression in satellite
cells may also be responsible for cell plasticity,
cooperating with Runx2-activated osteocyte-specific
genes to coordinate osteogenic differentiation. Further-
more, knockdown of MyoD1 has previously been shown
not to enhance satellite cell osteogenesis (Asakura et al.,
2001), which suggests that this myogenic factor does not
necessarily have an anti-osteogenic role. Finally, compara-
tively low levels of the terminal differentiation factor
myogenin, together with a lack of myoblast fusion,
suggests that ‘reserve’ cells are likely to represent a
population of activated muscle progenitors that have not
been fully primed for myogenic differentiation, but may
have a native or inducible osteogenic capacity.
Previous studies have highlighted the osteogenic poten-
tial of C2C12s (Katagiri et al., 1994). However, it appears
that no previous reports have specifically demonstrated
an osteogenic capacity within the ‘reserve’ cell population.
The present study has shown that culturing C2C12s in a 3D
collagen environment defines a method for the selection of
a pre-osteogenic ‘reserve’ cell population. These cells have
Figure 4. Determining the osteogenic capacity of ‘reserve’ cells. Photomicrographs and accompanying Alizarin red staining and quantification showed that ‘reserve’ cells
cultured in the presence of osteogenic medium exhibited no (a) observable or (b) quantifiable differences in the formation of calcified nodules after 7 days and 14 days in culture.
(c) quantitative real-time reverse-transcription polymerase chain reaction analysis identified a significantly (p < 0.05) higher expression of the master osteogenic regulator gene
Runx2 in the ‘reserve’ cell population when compared with C2C12 controls after 3 days of culture. Bar: 100 μm. *p < 0.05; polymerase chain reaction and Alizarin red
quantification data are represented as mean ± standard deviation (n = 3).
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been termed pre-osteogenic because they demonstrated a
comparative increase in the expression of the master oste-
ogenic regulator Runx2 compared with unselected C2C12
controls, but no corresponding increase in SP7 or AR stain-
ing. These findings suggest that this population is primed
for osteogenic differentiation, but that exogenous
osteoinductive proteins are likely required for the transi-
tion to occur. Significantly, the addition of exogenous
osteoinductive factors (BMP2 and PDGF-BB) promoted
mineralization in ‘reserve’ cell cultures, even in the absence
of osteogenicmediumwith no differences seen in the unse-
lected C2C12 controls. The fact that these cells were able to
mineralize in standard growth medium without the addi-
tion of osteogenicmedium suggests that ‘reserve’ cells were
able to utilize limited exogenous sources of calcium and
phosphate present within basic culture medium, such as
calcium chloride (0.2 g/l) and sodium monophosphate
(0.109 g/l), providing further evidence that these cells
were primed for osteogenic differentiation. Previous stud-
ies have demonstrated the osteoinductive effects of BMP2
within skeletal muscle (Katagiri et al., 1994; Kaihara
et al., 2004), and links are present between BMP-induced
ectopic bone formation and a rare genetic form of HO
termed fibrodysplasia ossificans progressiva (FOP) (Shore
et al., 2006). However, acquired HO may not be entirely
BMP dependent, with a large number of factors possibly
contributing to skeletal ossification at the wound site
(Chromy et al., 2013).
We demonstrate that exposure to PDGF-BB promoted
significantly more mineral deposition and expression of
key osteogenic markers in ‘reserve’ cell cultures than
BMP2, the current gold-standard osteoinductive factor in
animal studies of HO. This cytokine is elevated as platelets
infiltrate injured tissue following trauma (Liu et al., 2006)
and a previous link between PDGF-BB and ectopic ossifi-
cation has been found in studies examining the mecha-
nisms governing vascular calcification as a consequence
of atherosclerosis (Boucher and Gotthardt, 2004). In
addition, PDGF-BB synthesis is elevated in areas of low
oxygen tension via an association with hypoxia-inducible
factor-1 (HIF-1), a well-established protein linked with
HO (Schito et al., 2012). Perhaps the contribution of
Figure 5. Mineralization can be induced in the undifferentiated ‘reserve’ cell population. (a) Flow cytometry profiling and accompanying Alizarin red staining identified a rela-
tionship between the presence of Sca-1
+
/CD73
+
cells and the formation of calcified nodules. (b) Exposure to tumour necrosis factor (TNF)α, interleukin (IL)1, IL6, insulin-like
growth factor (IGF)-1 and basic fibroblast growth factor (bFGF) caused no significant increase in the number of Sca-1
+
/CD73
+
cells, and no corresponding mineralization was
observed. (c) Alizarin red quantification showed that mineralization in the isolated ‘reserve’ cell population was significantly (p < 0.05) enhanced when skeletal muscle con-
structs were exposed to platelet derived growth factor (PDGF)-BB or bone morphogenetic protein 2 (BMP2), respectively, when compared with untreated controls. (d) Gene ex-
pression analysis showed that PDGF-BB promoted a significant (p < 0.05) increase in Runx2 and SP7 when compared with BMP2, which reduced SP7 expression when compared
with C2C12 controls. All quantitative real-time reverse-transcription polymerase chain reaction analysis was performed at day 3 and normalized to untreated three-dimensional
controls using the ΔΔCT (Livak) method, indicated by the dashed lines. Coloured cells signify the addition of a growth/inflammatory factor. Bar: 100 μm. *p < 0.05, **p < 0.005;
flow cytometry, polymerase chain reaction and Alizarin red quantification data are represented as mean ± standard deviation (n = 3).
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PDGF-BB to HO has been most conclusively demonstrated
by a study utilising imatinib, a PDGF-BB antagonist, for
the treatment of ectopic bone growth. The study showed
that administration of imatinib significantly reduced the
volume of ectopic bone formed in an Achilles tenotomy
model of HO (Werner et al., 2013). However, it appears
that no correlation between PDGF-BB and skeletal muscle
ossification has been documented previously. Unlike
BMP2, PDGF-mediated activation of osteogenesis does
not occur via the Smad signalling pathway, which has
been consistently implicated in hereditary forms of HO,
such as FOP (Pignolo et al., 2011). It has been suggested
that PDGF-BB instead promotes osteogenic differentiation
in MSCs through activation of the ERK1/2 MAPK pathway
(Salasznyk et al., 2004), which has previously been iden-
tified as key pathway regulating osteoblast differentiation
and skeletal development (Ge et al., 2007). However,
further studies will be required to confirm the exact mech-
anism of PDGF-BB on mineralization in the reserve cell
population. A recent report on PDGF-BB-induced
activation of Smad1/5/8 transcription factors via Erk5
further sheds light on crosstalk between MAPK and Smad
signalling pathways (Tsioumpekou et al., 2016) and,
together with the finding of the present study that
exogenous PDGF-BB promoted mineralization in the
‘reserve’ cell population, collectively it corroborates the
importance of understanding the protein signalling
cascade in the context of pathological ossification. Future
work would involve verifying whether PDGF contribute to
HO initiation via mechanisms involving latent response of
traumatized muscle to overactive BMP signalling, as
proposed by Shi et al. (2013).
Figure 6. Principal component analysis (PCA) to determine main effects conducive to Sca-1
+
/CD73
+
phenotypic change. (a) Table and corresponding (b) flow cytometry data
displaying the 16 different combinations of growth and inflammatory factors applied to bioengineered skeletal muscle cultures and the resulting percentage Sca-1
+
/CD73
+
pos-
itivity observed. Coloured cells signify the addition of growth/inflammatory factors. (c) Linear regression analysis of the main effects of each growth/inflammatory factor on the
proportion of Sca-1
+
/CD73
+
cells. Flow cytometry data are represented as means ± standard deviation (n = 3). bFGF, basic fibroblast growth factor; BMP2, bone morphogenetic
protein 2; IGF-1, insulin-like growth factor-1; IL-1/IL-6, interleukin-1/interleukin-6; PDGF, platelet-derived growth factor; TGFβ, transforming growth factor β; TNFα, tumour ne-
crosis factor α.
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Mineral deposition within the ‘reserve’ cell population
appeared to correlate with the presence of a Sca-1+/
CD73+ phenotype, and the proposed mechanism by
which these cells may contribute to ectopic mineralization
in the skeletal muscle construct used in the present study
is shown in Figure 8. Of particular note was the finding
Figure 7. Pro-inflammatory cytokines tumour necrosis factor (TNF)α and interleukin (IL)1 mediate platelet derived growth factor (PDGF)-induced ectopic ossification in tissue-
engineered skeletal muscle. (a) Table displaying the combination of factors added to each culture and how this affected the proportion of Sca-1
+
/CD73
+
cells and the presence of
ectopic mineral. (b) Flow cytometry data and Alizarin red staining showing the mediating effects of pro-inflammatory cytokines on mineralization, and how this is related to the
proportion of Sca-1
+
/CD73
+
cells. (c) Quantification of the concentration of Alizarin red stain bound in PDGF-BB cultures exposed to pro-inflammatory cytokines IL1 and TNFα.
(d) Quantitative real-time reverse-transcription polymerase chain reaction gene expression analysis showing reductions in osteogenic regulators Runx2 and SP7, and the down-
stream hedgehog signalling factor Ptch1 in the presence of TNFα. Polymerase chain reaction was performed at day 3 with gene expression normalized to the untreated ‘reserve’
cells using the ΔΔCT (Livak) method. Coloured cells signify the addition of growth/inflammatory factors. Bars: 100 μm. *p < 0.05. Flow cytometry, polymerase chain reaction and
Alizarin red quantification data are represented as mean ± standard deviation (n = 3).
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that growth factors causing only minor (TGF-β) or no
(IGF-1) observable mineralization when added indepen-
dently, were shown to facilitate the formation of a Sca-
1+/CD73+ phenotype when added in combination with
other prominent factors linked with skeletal muscle
trauma and HO (i.e. synergistic effects of TGF-β and PDGF
observed). This identifies a method by which factors
secreted at the trauma site may indirectly contribute
towards ectopic ossification, further highlighting the
complexity of the association between post-trauma
inflammation and HO. The Sca-1+/CD73+ cells were
CD144– and, as such, independent of previously identified
non-myogenic, pro-osteogenic interstitial mesenchymal
progenitor cells (Uezumi et al., 2010). These cells also
did not express CD44 or CD90, thereby demonstrating
there had been no reversion to a mesenchymal stem cell
phenotype. Sca-1 is expressed by myoblasts as well as
stem and progenitor cells derived from a number of
tissues, including muscle-derived stem cells and myogenic
precursors recruited to sites of injury. Although the exact
function of this cell surface protein remains elusive previ-
ous studies have shown that Sca-1 null mice present with
osteoporosis, thereby identifying a link between Sca-1+
cells and bone quality (Holmes et al., 2007). CD73 is a
50 nucleotidase that converts ATP and AMP to adenosine,
and has been shown to promote osteogenic differentiation
of human mesenchymal stem cells and osteoblast differ-
entiation (Takedachi et al., 2012). The present study pro-
vides evidence to suggest a link between a Sca-1+/CD73+
phenotype and ectopic mineralization, and it is hypothe-
sized that this may result from the reversion of ‘reserve’
cells to an osteoprogenitor-like state. Previous studies
have previously demonstrated dedifferentiation of termi-
nally differentiated myoblasts (McGann et al., 2001; Chen
et al., 2005). In addition, within the context of acquired
HO, skeletal muscle cells have been shown to
de-differentiate into mononuclear cells capable of forming
myoblasts, satellite cells or muscle-derived stem cells in
response to injury, thereby further establishing a link
between myoblast dedifferentiation and HO (Mu et al.,
2011). This is relevant given that acquired HO occurs in
skeletal muscle as a consequence of trauma and suggests
that myoblast reversion to a pro-osteogenic cell type may
be linked with the post-trauma microenvironment.
Furthermore, the correlation between CD73+ ‘reserve’
cells and in vitro mineralization, together with findings
presented by Peterson et al. (2014) identifying that limit-
ing extracellular ATP can inhibit bone formation at the
site of HO (Peterson et al., 2014), implies that the
presence of a pro-osteogenic cell type is opportunistic
and can be primed in response to a number of permissive
microenvironmental factors.
Trauma is immediately followed by a hyper-
inflammatory response. In the present study it was shown
that the presence of pro-inflammatory cytokines, TNFα
and IL1, can mediate PDGF-induced mineralization.
Tumour necrosis factor α is produced by activated macro-
phages during the post-trauma inflammatory response,
and the potential benefits of using TNFα to prevent
endochondral ossification have been documented
(Yoshikawa et al., 1988). Furthermore, TNFα has a
prominent role in osteoclastogenesis, largely through its
interaction with IL1 (Charatcharoenwitthaya et al.,
2007). The finding that TNFα and IL1 blocked
PDGF-induced mineralization is highly pertinent because
non-steroidal anti-inflammatory drugs (NSAIDs) are
frequently prescribed as HO prophylactics (Beckmann
et al., 2014). These drugs are often administered in
Figure 8. Diagram depicting a possible mechanism governing ectopic mineralisation in the tissue-engineered skeletal muscle construct. C2C12 cells cultured in a three-dimen-
sional (3D) environment contain a population of cells that are able to fuse to form myotubes and a smaller population of cells that remain unfused, the so-called ‘reserve’ cells. In
the presence of osteoinductive factors, such as bone morphogenetic protein 2 (BMP2) or platelet derived growth factor (PDGF)-BB, a proportion of these ‘reserve’ cells adopts a
Sca-1
+
/CD73
+
phenotype. The phenotypically altered Sca-1
+
/CD73
+
population is osteogenic in nature and able to deposit a mineralized matrix. However, mineralization of the
Sca-1
+
/CD73
+
population is mediated by the presence of pro-inflammatory cytokines such as tumour necrosis factor α and interleukin 1. Hence, it is proposed that factors such as
the level of inflammation, timing of non-steroidal anti-inflammatory drug (NSAID) administration, and relative abundance of osteoinductive proteins are likely to influence the
outcome.
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combination with single-dose radiotherapy to prevent HO
formation following invasive surgeries such as total hip
arthroplasty. However, reports concerning the efficacy of
NSAID prophylaxis are mixed, and any association
between inflammation and the development of HO com-
plex. A recent study examining the mechanism by which
preoperative radiation therapy acts to reduce HO showed
that the number of immunological cells was significantly
increased within the irradiated area, with a corresponding
increase in pro-inflammatory cytokines, possibly suggest-
ing that inflammation is a negative regulator of HO (Hoff
et al., 2013). The results of the present study, in conjunc-
tion with the other studies described further suggest that
the presence of local inflammatory factors within skeletal
muscle following trauma acts to prevent ossification
within the myoblast population. These results consolidate
existing studies questioning the efficacy of NSAIDs as a
primary HO prophylactic, and suggest that the timing of
NSAID administration is likely to be crucial for effective
prevention of HO.
4.1. Limitations
Some of the limitations of the present study exist,
highlighting the need for further research that will build
on initial findings to fully clarify the role of PDGF-BB
and the immunological response during HO. First, it is
acknowledged that the concentration of PDGF-BB in vivo
fluctuates widely over the course of HO development,
with increases most likely to occur during platelet and
immune cell aggregation. In the present study the concen-
tration of PDGF applied was consistent with that reported
in in vitro studies throughout the literature. However, it is
acknowledged that there is a need for further study to
examine the effects of concentration and timing of
PDGF-BB dosing in the system. An absence of immunolog-
ical cells also restricts the number of conclusions that can
be drawn in relation to the role of inflammation during
HO, as the chemoattractive and activating effects of
PDGF-BB on these cells was outside the scope of the
study. Lastly, because HO is a highly complex condition
that is likely to result from the combinative effects of
multiple cell types it is necessary to consider the effects
of PDGF-BB on local and migratory stem cells, endothelial
cells and pericytes, which have all been implicated in this
debilitating condition (Davies et al., 2015).
5. Conclusion
In the tissue-engineered model used, PDGF-BB was shown
to be a potent inducer of skeletal muscle ossification. The
presence of pro-inflammatory cytokines, TGFβ and IL1,
directly modulated the action of this osteoinductive factor
on a population of undifferentiated ‘reserve’ cells, thereby
providing a possible route for regulating HO and
coordinating bone formation for regenerative applica-
tions. However, the processes governing HO are complex
and the role of the post-trauma inflammatory response
is likely to be multifaceted. Therefore, the osteoregulatory
effects of these cytokines will need to be tested in other
contributory cell populations such as local and circulating
osteogenic precursors, endothelial precursor cells and
skeletal muscle progenitors (Davies et al., 2015). There
is also evidence to suggest that the hyper-inflammatory
response to trauma may be in part genetically determined,
suggesting that certain individuals are predisposed to
developing HO after suffering a trauma.
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